Pharma Pulse 2/12/25: How Uncertainty & Distrust Damage Relationships with Patients, Health of the Biosimilars Industry & more

How Uncertainty & Distrust Damage Relationships with Patients

In this Pharmaceutical Executive video interview, Ian Baer, Founder & CEO of Sooth, identifies how uncertainty of where to find information, coupled with distrust, can damage the relationship between pharmaceutical companies and the patients they aim to serve.

Health of the Biosimilars Industry, Getting Rid of Clinical Trials, PBMs As Obstacles and Other Biosimilar Topics

As part of Managed Healthcare Executive’s coverage of biosimilars and managed care in 2025, we will be reaching out to leaders in industry and managed care, and outside experts and analysts who can provide insight and understanding into biosimilars and their market dynamics. Managing Editor Peter Wehrwein spoke recently with Craig Burton, MBA, executive director of the Biosimilars Council and senior vice president of policy and strategic alliances for the Association for Accessible Medicines. The Biosimilars Council is part of the association, a trade association of generic and biosimilar distributors and manufacturers.

Lilly Sells $6.5 Billion of Bonds for Cancer Drug Purchase

Eli Lilly & Co. tapped the US investment-grade bond market on Monday to help finance its roughly $2.5 billion purchase of a cancer drug from Scorpion Therapeutics Inc.

Synedgen Announces Appointment of Dr. Laura Saward as Chief Scientific Officer

Synedgen, Inc., a biotechnology company targeting human glycobiology to treat gastrointestinal diseases, today announced the appointment of Dr. Laura Saward, PhD, as the company’s Chief Scientific Officer.

Dr. Saward is an accomplished biotechnology executive with more than 25 years of experience in therapeutic drug development from preclinical to licensure. She will lead Synedgen’s scientific strategy to further the company’s development pipeline and government partnerships.

James Plummer on LinkedIn

At McKesson, we're not just about logistics; we're about pioneering pathways to a healthier future.

I'm pleased to share thatPharmaceutical Commerce Magazine recently interviewed Christopher Armstrong to get his thoughts on the direction of our industry. Check it out!

Have news you want us to share in Pharma Pulse? Reach out to Editor Miranda Schmalfuhs